25
08, 2023
24
07, 2023
1
05, 2023
25
04, 2023
SB 170
A post-employment restrictive covenant between a health care provider and the health care employee is void.
15
03, 2023
Healthcare Merger Watch Q1 2023: Nationwide Cross-Market Merger Mania
In this first healthcare merger watch of 2023, we highlight some consolidation activities from the first quarter in the healthcare industry. In a trend that has continued in recent years, healthcare entities in the latest proposed and pending deals are increasingly exploring consolidation in new and innovative ways, across different geographic regions and involving different healthcare players in the industry. Even though federal and state antitrust enforcers often successfully challenge traditional, horizontal mergers and acquisitions, transactions involving cross-market consolidation are typically not challenged due to less straightforward legal and economic theories in proving potential [...]
15
02, 2023
18
01, 2023
HB 210
This bill requires the Health Data Committee to annually issue a report on primary care spending within the state, establish a plan for collecting data from data suppliers to determine measurements of cost and reimbursements for risk-adjusted episodes of health care; report on rate and price increases by health care providers; and publish an annual report on primary care spending within the state.
18
01, 2023
HB 223
This bill creates price caps for certain diabetic supplies: requires a health benefit plan to cap the price of the insulin pumps; requires a health benefit plan to cap the price of the continuous blood glucose monitors
15
12, 2022
Healthcare Consolidation Q4 2022: Cross-Market Mergers Continue Apace
2022 has been an active year in healthcare consolidation as well as for merger challenges and enforcement. As we approach the year end, healthcare deals continued as many entities seek to close the transactions before the new year. Increasingly, as seen in the 4th quarter, healthcare deals are shifting to cross-market transactions, making review and enforcement efforts more challenging. In case you missed it, this final Litigation and Enforcement Highlights of the year will help you catch up on some of the cross-market deals in Q4 2022 that caught our attention. Advocate Aurora [...]
17
06, 2022